Company news

Medtronic Wins FDA Clearance for Hugo RAS System in General Surgery

Medtronic announced that the FDA has cleared the Hugo robotic-assisted surgery system for general surgery, covering cholecystectomy, gastric bypass, ventral hernia, small bowel resection, inguinal hernia and appendectomy, procedures totaling about 3.5 million annually in the U.S.

Published · Updated · Source: Surgical Robotics Technology · AI translation
Illustration
Medtronic plc announced that the U.S. Food and Drug Administration has cleared the Hugo robotic-assisted surgery (RAS) system for use in general surgery procedures. The clearance covers all upper abdominal general surgical procedures, including but not limited to cholecystectomy, Roux-en-Y gastric bypass, ventral hernia and small bowel resection. Lower abdominal procedures of inguinal hernia and appendectomy were also cleared. Medtronic said these procedures account for about 3.5 million surgeries annually in the U.S., more than half of all soft-tissue procedures performed in the country each year. Medtronic said the Hugo RAS system is in clinical use at a growing number of health systems and hospitals across the U.S., and that globally its procedure growth is running at more than two times the robotic surgery market and is on track to surpass 50,000 procedures by the end of the Medtronic fiscal year. This information comes from the original report by Surgical Robotics Technology and was organized by AI.
Read the original source

Related news